Tandem Diabetes Care, Inc., based in San Diego, has initiated a voluntary recall of its t:slim X2 insulin pumps following reports of malfunctions that have resulted...
Neurizon Therapeutics has announced a delay in the decision regarding its Investigational New Drug (IND) application, attributing the setback to “strain” within the U.S. Food and...
The U.S. Food and Drug Administration (FDA) has announced the launch of the new “FDA PreCheck” program aimed at strengthening domestic drug manufacturing capabilities. This initiative...
Groundbreaking research has revealed that two FDA-approved drugs, previously used to treat cancer, have the potential to reverse the effects of Alzheimer’s disease and restore memory...
